{"schema_version":"secwatch.filing_event.v1","accession":"0001740797-24-000056","form_type":"8-K","ticker":"AVAI","cik":"0001740797","company_name":"AVAI BIO, INC.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.420431+00:00","generated_at":"2026-05-30T02:04:10.791855+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avant to fund up to $20M, forms 50/50 JV with Ainnova for retina AI tech","bullets":["Avant contributes up to $20M in capital over 12 months to new JV 'Ai-Nova Acquisition Corp'.","Ainnova contributes Vision AI technology portfolio for retinal disease detection and scanning.","Ownership split 50% Avant, 50% Ainnova; JV to issue 2,000,000 shares.","Profit distribution: first to Ainnova for contributed business value, then Avant for capital, then pro-rata.","Territories include US, Canada, Europe; JV to seek third-party licensing and strategic transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001740797-24-000056","json":"https://secwatch.observer/filing/0001740797-24-000056.json","markdown":"https://secwatch.observer/filing/0001740797-24-000056.md","text":"https://secwatch.observer/filing/0001740797-24-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000056/0001740797-24-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740797/000174079724000056/report8k_avai.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:04:10.791855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}